Answer
Brolucizumab should not be used during pregnancy unless the potential benefit outweighs the potential risk to the foetus, because human pregnancy data are absent or limited and there is a potential risk to embryofoetal development.
Sources for this answer
- Beovu 120 mg/ml solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked